215 Publications (Page 8 of 9)
2003
Synthesis of MMP inhibitor radiotracer [11C]CGS 25966, a new potential pet tumor imaging agentFei, Xiangshu⋅Fei, Xiangshu⋅Zheng, Qi‐Huang⋅Zheng, Qi‐Huang⋅Liu, Xuan⋅Liu, Xuan⋅Wang, Ji‐Quan⋅Wang, Ji‐Quan⋅Stone, K. Lee⋅Stone, K. Lee⋅Miller, Kathy D⋅Miller, Kathy D⋅Sledge, George W⋅Sledge, George W⋅Hutchins, Gary D and Hutchins, Gary DJournal of Labelled Compounds and Radiopharmaceuticals, vol. 46, (no. 4), pp. 351, 30 March 2003.
| Journal Article
Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents.Fei, Xiangshu⋅Zheng, Qi H⋅Liu, Xuan⋅Wang, Ji Q⋅Sun, Hui B⋅Mock, Bruce H⋅Stone, K L⋅Miller, Kathy D⋅Sledge, George W and Hutchins, Gary DBioorganic & medicinal chemistry letters, vol. 13, (no. 13), pp. 2217-22, 2003/Jul/7.
| Journal Article
Thermoacoustic molecular imaging of small animals.Kruger, Robert A⋅Kiser, William L⋅Reinecke, Daniel R⋅Kruger, Gabe A and Miller, Kathy DMolecular imaging : official journal of the Society for Molecular Imaging, vol. 2, (no. 2), pp. 113-23, 2003/Apr.
| Journal Article
The Snark is a Boojum: the continuing problem of drug resistance in the antiangiogenic era.Miller, Kathy D⋅Sweeney, C J and Sledge, G WAnnals of Oncology, vol. 14, (no. 1), pp. 20-8, 2003/Jan.
| Journal Article
2002
[11C]Choline as a potential PET marker for imaging of breast cancer athymic mice.Zheng, Qi-Huang⋅Zheng, Qi Huang⋅Stone, K.Lee⋅Stone, K L⋅Mock, Bruce H⋅Mock, Bruce H⋅Miller, Kathy D⋅Miller, Kathy D⋅Fei, Xiangshu⋅Fei, Xiangshu⋅Liu, Xuan⋅Liu, Xuan⋅Wang, Ji-Quan⋅Wang, Ji-Quan⋅Glick-Wilson, Barbara E⋅Glick-Wilson, Barbara E⋅Sledge, George W⋅Sledge, George W⋅Hutchins, Gary D and Hutchins, Gary DNuclear medicine and biology, vol. 29, (no. 8), pp. 803-7, 2002/Nov.
| Journal Article
Angiogenesis and antiangiogenic therapySledge, Jr, George W and Miller, Kathy DCurrent problems in cancer, vol. 26, (no. 1), pp. 1, 2002 Jan-Feb.
| Journal Article
Angiogenesis and antiangiogenic therapy.Sledge, George W and Miller, Kathy DCurrent Problems in Cancer, vol. 26, (no. 1), pp. 1-60, 2002 Jan-Feb.
| Journal Article
Angiogenesis and Antiangiogenic TherapySledge, George W and Miller, Kathy DCurrent Problems in Cancer, vol. 26, (no. 1), pp. 59, 2002.
| Journal Article
A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.Miller, Kathy D⋅Gradishar, William J⋅Schuchter, L⋅Sparano, Joseph A⋅Cobleigh, M⋅Robert, N⋅Rasmussen, H and Sledge, George WAnnals of oncology : official journal of the European Society for Medical Oncology / ESMO. , vol. 13, (no. 8), pp. 1220-4, 2002/Aug.
| Journal Article
Combined anti-microtubule therapy: a phase II study of weekly docetaxel plus estramustine in patients with metastatic breast cancer.Soule, S E⋅Miller, Kathy D⋅Porcu, Pierluigi⋅Ansari, R⋅Fata, F⋅McClean, J W⋅Zon, R⋅Sledge, G W and Einhorn, L HAnnals of Oncology, vol. 13, (no. 10), pp. 1612-5, 2002/Oct.
| Journal Article
HER-2/neu expression in germ cell tumoursSoule, S⋅Baldridge, L⋅Kirkpatrick, K⋅Cheng, L⋅Gilbert, J L⋅Smith, L R⋅Thurston, V C⋅Vance, G H⋅Einhorn, L and Miller, KJournal of Clinical Pathology, vol. 55, (no. 9), Sep 2002.
| Journal Article
Issues and challenges for antiangiogenic therapiesMiller, Kathy DBreast Cancer Research and Treatment, vol. 75, pp. S45, Oct 2002.
| Journal Article
Issues and challenges for antiangiogenic therapies.Miller, Kathy DBreast cancer research and treatment. , vol. 75 Suppl 1, pp. S45-50; discussion S57-8, 2002/Oct.
| Journal Article
Issues and challenges for antiangiogenic therapies.Miller, Kathy DBreast Cancer Research and Treatment, vol. 75 Suppl 1, pp. S45-50; discussion S57-8, 2002/Oct.
| Journal Article
Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.Zheng, Qi Huang⋅Fei, Xiangshu⋅Liu, Xuan⋅Wang, Ji-Quan⋅Bin Sun, Hui⋅Mock, Bruce H⋅Lee Stone, K⋅Martinez, Tanya D⋅Miller, Kathy D⋅Sledge, George W and Hutchins, Gary DNuclear medicine and biology, vol. 29, (no. 7), pp. 761-70, 2002/Oct.
| Journal Article
Synthesis of MMP inhibitor radiotracers [11C]methyl‐CGS 27023A and its analogs, new potential PET breast cancer imaging agentsFei, Xiangshu⋅Fei, Xiangshu⋅Zheng, Qi‐Huang⋅Zheng, Qi‐Huang⋅Hutchins, Gary D⋅Hutchins, Gary D⋅Liu, Xuan⋅Liu, Xuan⋅Stone, K. Lee⋅Stone, K. Lee⋅Carlson, Kathy A⋅Carlson, Kathy A⋅Mock, Bruce H⋅Mock, Bruce H⋅Winkle, Wendy L⋅Winkle, Wendy L⋅Glick‐Wilson, Barbara E⋅Glick‐Wilson, Barbara E⋅Miller, Kathy D⋅Miller, Kathy D⋅Fife, Rose S⋅Fife, Rose S⋅Sledge, George W⋅Sledge, George W⋅Sun, Hui Bin⋅Sun, Hui Bin⋅Carr, Raymond E and Carr, Raymond EJournal of Labelled Compounds and Radiopharmaceuticals, vol. 45, (no. 6), pp. 470, May 2002.
| Journal Article
Synthesis of radiolabeled O6‐benzylguanine derivatives as new potential PET tumor imaging agents for the DNA repair protein O6‐alkylguanine‐DNA alkyltransferaseZheng, Qi‐Huang⋅Zheng, Qi‐Huang⋅Liu, Xuan⋅Liu, Xuan⋅Fei, Xiangshu⋅Fei, Xiangshu⋅Wang, Ji‐Quan⋅Wang, Ji‐Quan⋅Ohannesian, David W⋅Ohannesian, David W⋅Erickson, Leonard C⋅Erickson, Leonard C⋅Stone, K. Lee⋅Stone, K. Lee⋅Martinez, Tanya D⋅Martinez, Tanya D⋅Miller, Kathy D⋅Miller, Kathy D⋅Hutchins, Gary D and Hutchins, Gary DJournal of Labelled Compounds and Radiopharmaceuticals, vol. 45, (no. 14), pp. 1252, December 2002.
| Journal Article
2001
Adjuvant chemotherapy for tumors of one centimeter or less: the law of diminishing returns.Soule, S E and Miller, K DCurrent oncology reports, vol. 3, (no. 6), pp. 529-535, November 2001.
| Journal Article
Gemcitabine, paclitaxel, and trastuzumab in metastatic breast cancer.Miller, Kathy D⋅Sisk, J⋅Ansari, R⋅Gize, G⋅Nattam, S⋅Pennington, K⋅Monaco, F and Sledge, George WOncology, vol. 15, (no. 2 Suppl 3), pp. 38-40, 2001/Feb.
| Journal Article
Selection bias in clinical trials.Miller, Kathy D⋅Rahman, Z U and Sledge, G WBreast disease. , vol. 14, pp. 31-40, 2001.
| Journal Article
The antiangiogenic property of docetaxel is synergistic with a recombinant humanized monoclonal antibody against vascular endothelial growth factor or 2-methoxyestradiol but antagonized by endothelial growth factors.Sweeney, Christopher J⋅Miller, Kathy D⋅Sissons, S E⋅Nozaki, S⋅Heilman, D K⋅Shen, J and Sledge, George WCancer Research, vol. 61, (no. 8), pp. 3369-72, 2001/Apr/15.
| Journal Article
2000
A Phase II trial of high dose epirubicin in patients with advanced breast carcinomaMiller, Kathy D⋅Miller, Kathy D⋅Munshi, Nikhil⋅Munshi, Nikhil⋅Loesch, David⋅Loesch, David⋅Einhorn, Lawrence H⋅Einhorn, Lawrence H⋅Sledge, George W and Sledge, George WCancer, vol. 88, (no. 2), pp. 380, 15 January 2000.
| Journal Article
Breast cancer in vivo: contrast enhancement with thermoacoustic CT at 434 MHz-feasibility study.Kruger, Robert A⋅Miller, K D⋅Reynolds, H E⋅Kiser, W L⋅Reinecke, D R and Kruger, G ARadiology, vol. 216, (no. 1), pp. 279-83, 2000/Jul.
| Journal Article
Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial.Quella, S K⋅Loprinzi, Charles L⋅Barton, Debra L⋅Knost, J A⋅Sloan, Jeff A⋅LaVasseur, B I⋅Swan, D⋅Krupp, K R⋅Miller, K D and Novotny, P JJournal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 18, (no. 5), pp. 1068-74, 2000/Mar.
| Journal Article